In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43

Previous data have suggested an antiviral effect of teriflunomide, including against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the agent underlying the ongoing COVID-19 pandemic. We undertook an in vitro investigation to evaluate the inhibitory activity of teriflunomide against S...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Paul, Geertsen, Svend S., Lublin, Alex L., Potter, Michelle C., Gladysheva, Tatiana, Gregory, Jill S., Rufi, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682045/
https://www.ncbi.nlm.nih.gov/pubmed/36437966
http://dx.doi.org/10.1016/j.bbrep.2022.101395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682045/
https://www.ncbi.nlm.nih.gov/pubmed/36437966
http://dx.doi.org/10.1016/j.bbrep.2022.101395

Ejemplares similares